dc.contributor.author | Kazemzadeh, M | |
dc.contributor.author | Safaralizadeh, R | |
dc.contributor.author | Feizi, MA | |
dc.contributor.author | Somi, MH | |
dc.contributor.author | Shokoohi, B | |
dc.date.accessioned | 2018-08-26T05:36:28Z | |
dc.date.available | 2018-08-26T05:36:28Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.5301/tj.5000426 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/39532 | |
dc.description.abstract | Long non-coding RNAs (lncRNAs), a class of regulatory RNAs, play a major role in various cellular processes. Long intergenic non-coding RNAs (lincRNAs), a subclass of lncRNAs, are involved in the trans- and cis-regulation of gene expression. In the case of cis-regulation, by recruiting chromatin-modifying complexes, lincRNAs influence adjacent gene expression.We used quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) to evaluate the coexpression of LOC100287225, a lincRNA, and DCC, one of its adjacent genes that is often decreased in colorectal cancer, in pairs of tumor and adjacent tumor-free tissues of 30 colorectal cancer patients.The qRT-PCR results revealed the misregulation of these genes during tumorigenesis. Their relative expression levels were significantly lower in tumor tissues than adjacent tumor-free tissues. However, the analysis found no significant correlation between reduced expression of these genes.Our study demonstrated the concurrent misregulation of DCC and LOC100287225 in colorectal cancer. | |
dc.language.iso | English | |
dc.relation.ispartof | Tumori | |
dc.subject | DCC Receptor | |
dc.subject | Female | |
dc.subject | Gene Expression Regulation, Neoplastic | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | RNA, Long Noncoding | |
dc.subject | Real-Time Polymerase Chain Reaction | |
dc.subject | Receptors, Cell Surface | |
dc.subject | Reverse Transcriptase Polymerase Chain Reaction | |
dc.subject | Tumor Suppressor Proteins | |
dc.title | Misregulation of the dependence receptor DCC and its upstream lincRNA, LOC100287225, in colorectal cancer. | |
dc.type | article | |
dc.citation.volume | 103 | |
dc.citation.issue | 1 | |
dc.citation.spage | 40 | |
dc.citation.epage | 43 | |
dc.citation.index | Pubmed | |
dc.identifier.DOI | https://doi.org/10.5301/tj.5000426 | |